Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie Schier

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oncology|October 8, 2005
Stem cell relationships and the origin of gastrointestinal cancerStefanie Schier, Nicholas A Wright
Gastroenterology|March 15, 2006
Isolation of gut SP cells does not automatically enrich for stem cellsMalcolm R Alison, Richard Poulsom, Mairi Brittan, et al.
Virchows Archiv : an International Journal of Pathology|June 6, 2009
Stem cells and solid cancersStuart A C McDonald, Trevor A Graham, Stefanie Schier, et al.
British Journal of Clinical Pharmacology|February 6, 2020
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologicsAnne Bellon, Jessie Wang, Andrej Skerjanec, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oncology|October 8, 2005
Stem cell relationships and the origin of gastrointestinal cancerStefanie Schier, Nicholas A Wright
Gastroenterology|March 15, 2006
Isolation of gut SP cells does not automatically enrich for stem cellsMalcolm R Alison, Richard Poulsom, Mairi Brittan, et al.
Virchows Archiv : an International Journal of Pathology|June 6, 2009
Stem cells and solid cancersStuart A C McDonald, Trevor A Graham, Stefanie Schier, et al.
British Journal of Clinical Pharmacology|February 6, 2020
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologicsAnne Bellon, Jessie Wang, Andrej Skerjanec, et al.
Pageof 1